Category: Chronic Pulmonary Disorders

Chronic Pulmonary Disorders

Alpha-1 Antitrypsin Deficiency Drug Enters Ph3 Trial

Grifols enrolled the first patient in its Phase 3 SWIFT-SC clinical trial to evaluate its subcutaneous Alpha1-Proteinase Inhibitor for the treatment of alpha1-antitrypsin (AAT) deficiency.

Chronic Pulmonary Disorders

World Bronchiectasis Conference 2026 Highlights New Tools and Patient Resources

Experts and healthcare organizations gathered in Germany for the 9th World Bronchiectasis Conference to share updates on clinical care, research findings, and new digital resources.

Chronic Pulmonary Disorders

Inhaled Vitamin D for COPD, Asthma

Researchers suggest delivering vitamin D directly to the lungs could bypass the limitations of oral supplements in treating COPD and asthma.

Asthma

8 Recommendations for Asthma Patient Education

This article will provide 8 recommendations for effective patient education regarding inhaled medications used in treating/preventing asthma symptoms and flare-ups.

COPD

Nebulized Dual Bronchodilator Aero-007 Improved COPD Lung Function

AERO-007 demonstrated significant lung function improvements over 24 hours in patients with moderate-to-severe COPD.

Cystic fibrosis

Cystic Fibrosis Patient Receives Quadruple Transplant

A 28-year-old cystic fibrosis patient underwent a 36-hour quadruple organ transplant for both lungs, a liver, and a kidney from a single donor.

Pulmonary Fibrosis

Nebulized Treprostinil Preserved IPF Lung Function

Phase 3 trial results show significant reductions in clinical worsening and acute exacerbations for patients with idiopathic pulmonary fibrosis (IPF).

Allergies

Microplastics May Intensify Immune Response to Common Allergens

New research suggests that microplastic particles can bind to allergens and carry them deeper into the respiratory system.

Other Chronic Diseases

Inhaled Molgramostim Improved Exercise Capacity

Phase 3 clinical trial data shows improvements in walking distance and duration for patients with autoimmune pulmonary alveolar proteinosis treated with inhaled molgramostim.